Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

RBC Capital ups price target on Hikma

(Sharecast News) - RBC Capital Markets has upped both forecasts and its price target for blue chip generics specialist Hikma Pharmaceuticals. The broker said Hikma had recently provided mid-term guidance that "reflects growing optimism about the Rx and injectables businesses".

It continued: "This adds to the positive outlook for the branded unit, communicated in late 2024. Overall, Hikma anticipates three-year revenue growth of 6% to 8% per annual, and core operating profit growth of 7% to 9% per annum."

RBC has therefore increased its 2027 forecasts for earnings before interest and tax by 9%, and the price target by 3%, to 2,635p.

It concluded: "With 27% upside, we reiterate our 'outperform' recommendation."

As at 1330 BST, shares in Hikma were largely flat at 2,078p.

Share this article

Related Sharecast Articles

US could release $20bn in frozen funds if Iran gives up uranium stockpile - report
(Sharecast News) - The US is reportedly considering the release of $20bn in frozen Iranian funds in return for Iran giving up its stockpile of enriched uranium as part of negotiations over a three-page plan to end the war.
CAB Payments shares drop as Helios won't support StoneX bid
(Sharecast News) - Shares in CAB Payments dropped on Friday after major shareholder Helios Investment Partners said it would not support a takeover offer from rival bidder StoneX despite the recommendation from the board of British payment processing and foreign exchange business.
Quantum Helium raises £5m to strengthen balance sheet
(Sharecast News) - Quantum Helium said on Friday that it has raised £5m through an institutional placing, strengthening its balance sheet as it advances development across its US helium projects.
Quantum Helium raises £5m to strengthen balance sheet
(Sharecast News) - Quantum Helium said on Friday that it has raised £5m through an institutional placing, strengthening its balance sheet as it advances development across its US helium projects.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.